COLL (STOCKS)
Collegium Pharmaceutical, Inc. Common Stock
$35.620000
+0.150000 (+0.42%)
Prev close: $35.470000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Vikram Karnani
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,131.37M
- Employees
- 357
- P/E (TTM)
- 20.44
- P/B (TTM)
- 3.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $780.57M |
| Benefits Costs and Expenses | $687.95M |
| Cost Of Revenue | $317.31M |
| Costs And Expenses | $687.95M |
| Gross Profit | $463.26M |
| Operating Expenses | $283.62M |
| Selling, General, and Administrative Expenses | $284.80M |
| Operating Income/Loss | $179.64M |
| Income/Loss From Continuing Operations After Tax | $62.87M |
| Income/Loss From Continuing Operations Before Tax | $92.62M |
| Income Tax Expense/Benefit | $29.75M |
| Income Tax Expense/Benefit, Deferred | -$25.66M |
| Net Income/Loss | $62.87M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $62.87M |
| Net Income/Loss Available To Common Stockholders, Basic | $62.87M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.98 |
| Diluted Earnings Per Share | $1.73 |
| Basic Average Shares | 31,706,429 |
| Diluted Average Shares | 39,701,693 |
| Assets | $1.66B |
| Current Assets | $691.41M |
| Inventory | $40.91M |
| Other Current Assets | $650.50M |
| Noncurrent Assets | $965.42M |
| Fixed Assets | $12.01M |
| Intangible Assets | $669.51M |
| Other Non-current Assets | $283.90M |
| Liabilities | $1.36B |
| Current Liabilities | $440.03M |
| Accounts Payable | $10.66M |
| Wages | $3.38M |
| Other Current Liabilities | $425.99M |
| Noncurrent Liabilities | $915.13M |
| Equity | $301.68M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $301.68M |
| Liabilities And Equity | $1.66B |
| Net Cash Flow From Operating Activities | $329.32M |
| Net Cash Flow From Operating Activities, Continuing | $329.32M |
| Net Cash Flow From Investing Activities | -$63.53M |
| Net Cash Flow From Investing Activities, Continuing | -$63.53M |
| Net Cash Flow From Financing Activities | -$110.25M |
| Net Cash Flow From Financing Activities, Continuing | -$110.25M |
| Net Cash Flow | $155.55M |
| Net Cash Flow, Continuing | $155.55M |
| Comprehensive Income/Loss | $63.13M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $63.13M |
| Other Comprehensive Income/Loss | $264.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $264.00K |